How a Twitter hashtag provides insights for doctors and support for people with breast cancer
Since first appearing in 2011, #BCSM has been used on the social media platform more than 830,000 times.
cancer
Results
UCLA physician-scientist elected to National Academy of Medicine
A pioneer in cancer immunology, Dr. Antoni Ribas has devoted his career to developing and refining new therapies for malignant melanoma.
Virus-mimicking drug helps immune system target cunning cancer cells
The research opens up the possibility of using drugs that simulate viruses to overcome immunotherapy resistance in melanoma.
UCLA draws record $1.4 billion in research funding
Spanning medicine, math and nanomaterials, support for campus scientific studies has grown almost 40% in five years.
UCLA researchers’ efforts to combat melanoma gets $13M boost from NIH
The team will investigate the mechanisms of treatment resistance, laying the groundwork for new and improved combination therapies.
As nation mourns Ruth Bader Ginsburg, a look at advances in pancreatic cancer treatment
One of the most effective preventive measures is germline sequencing, which can detect gene mutations known to increase disease risk.
Chemotherapy is used to treat less than 25% of people with localized sarcoma
Research brief: UCLA researchers found that chemotherapy is often underutilized when treating adults with sarcoma, a rare type of cancer of the soft tissues or bone.
Researchers ID new target in drive to improve immunotherapy for cancer
Research brief: A new combination treatment shows success in a mouse model of advanced head and neck carcinoma.
Doctors motivated by both health, malpractice concerns when ordering additional tests
Research brief: A study shows that while both are factors, a higher proportion of physicians report patients' safety as a concern.
School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
Research brief: A study shows that the proportion of vaccinated adolescents is higher in most states that require students to receive the vaccine.
$5.75M grant to help researchers study role of obesity in development of pancreatic cancer
The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.
New treatment extends lives of people with most common type of liver cancer
The immunotherapy drug combination is currently being reviewed for approval under a new FDA pilot program.
Brain tumors respond well to combo of radiation, schizophrenia drug
By repurposing drugs originally intended for other uses, scientists are pushing forward the fight against cancer.
A step toward a more efficient way to make gene therapies to attack cancer, genetic disorders
“We hope our method could be used in the future to prepare treatments that can be performed at the patient’s bedside,” said UCLA’s Paul Weiss.
Drug prevents cognitive impairment in mice after radiation treatment for brain tumors
Research brief: The experiment represents one of a very few instances in which a drug reduced cognitive decline in animals after radiation treatment.
At the forefront of esophageal health
A Q&A with Dr. Eric Esrailian on the Robert G. Kardashian Center for Esophageal Health and outreach efforts around COVID-19.
Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
A UCLA study shows that radiation therapy can be cut from five weeks to five days.
Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds
The patch significantly prolonged survival and reduced the growth of tumors in mice.
Botanical drug is shown to help patients with head and neck cancers
Research brief: The drug is made up of compounds produced by plants, including curcumin. Curcumin has been tested to help fight multiple cancers because it is an antioxidant that reduces swelling and inflammation.
Researchers identify possible new combination treatment for advanced melanoma
Research brief: When tested in mice with melanoma tumors that were unlikely to stimulate an immune response, the approach increased the number of anti-tumor immune cells.
$18 million gift will expand whole-person care for patients and families facing cancer
The funds will help the Simms/Mann–UCLA Center for Integrative Oncology expand its reach to community clinics.
Targeted therapy drug helps women with aggressive breast cancer live longer
The drug combination should be a first line of treatment, UCLA researchers say.
UCLA study shows inhibition of gene helps overcome resistance to immunotherapy
A combination approach could be new strategy for people with advanced cancers.
Taming chronic inflammation may reduce illness, save lives
Scientists from 22 institutions, including UCLA, call for early diagnosis, prevention and treatment to reduce the risk of chronic diseases.
Automated technique helps identify cancer cell metabolism inhibitors
Research brief: The new method, using robotics, will speed up how researchers test for therapies that block the metabolism of non-small-cell lung cancer tumors.